oHSV-P10 reduces glioma stem cell enrichment after oncolytic HSV therapy.

Sahu, Upasana; Mullarkey, Matthew P; Pei, Guangsheng; Zhao, Zhongming; Hong, Bangxing; Kaur, Balveen

Sahu, Upasana; Mullarkey, Matthew P; Pei, Guangsheng; Zhao, Zhongming; Hong, Bangxing; Kaur, Balveen.

Afiliação

Sahu U; Department of Neurosurgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Mullarkey MP; Department of Neurosurgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Pei G; Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Zhao Z; Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Hong B; Department of Neurosurgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Kaur B; Department of Neurosurgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

Mol Ther Oncolytics ; 29: 30-41, 2023 Jun 15.

Article em En | MEDLINE | ID: mdl-37114074

Palavras-chave

IL6; MT: Regular Issue; STAT3; glioblastoma; glioma stem cells; irradiation; oncolytic HSV1

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google